1
|
Pettinato G, Manivel JC, De Rosa N and
Dehner LP: Inflammatory myofibroblastic tumor (plasma cell
granuloma). Clinicopathologic study of 20 cases with
immunohistochemical and ultrastructural observations. Am J Clin
Pathol. 94:538–546. 1990.PubMed/NCBI
|
2
|
Zhao JJ, Ling JQ, Fang Y, Gao XD, Shu P,
Shen KT, Qin J, Sun YH and Qin XY: Intra-abdominal inflammatory
myofibroblastic tumor: Spontaneous regression. World J
Gastroenterol. 20:13625–13631. 2014. View Article : Google Scholar : PubMed/NCBI
|
3
|
World Health Organization Classification
of Tumors: Inflammatory myofibroblastic tumor. Pathology and
Genetics of Tumors of Soft Tissue and Bone (Lyon). IARC Press.
91–93. 2002.
|
4
|
Fukano R, Matsubara T, Inoue T, Gondo T,
Ichiyama T and Furukawa S: Time lag between the increase of IL-6
with fever and NF-kappaB activation in the peripheral blood in
inflammatory myofibroblastic tumor. Cytokine. 44:293–297. 2008.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Sakurai H, Hasegawa T, Watanabe S, Suzuki
K, Asamura H and Tsuchiya R: Inflammatory myofibroblastic tumor of
the lung. Eur J Cardiothorac Surg. 25:155–159. 2004. View Article : Google Scholar : PubMed/NCBI
|
6
|
Coffin CM, Hornick JL and Fletcher CD:
Inflammatory myofibroblastic tumor: Comparison of
clinicopathologic, histologic, and immunohistochemical features
including ALK expression in atypical and aggressive cases. Am J
Surg Pathol. 31:509–520. 2007. View Article : Google Scholar : PubMed/NCBI
|
7
|
Sokai A, Enaka M, Sokai R, Mori S, Mori S,
Gunji M, Fujino M and Ito M: Pulmonary inflammatory myofibroblastic
tumor harboring EML4-ALK fusion gene. Jpn J Clin Oncol. 44:93–96.
2014. View Article : Google Scholar : PubMed/NCBI
|
8
|
Denis DJ, Elayoubi K, Weil AG, Berthelet F
and Bojanowski MW: Inflammatory myofibroblastic tumors of the
central nervous system that express anaplastic lymphoma kinase have
a high recurrence rate. Surg Neurol Int. 4:702013. View Article : Google Scholar : PubMed/NCBI
|
9
|
Karashima T, Taniguchi Y, Shimamoto T, Nao
T, Nishikawa H, Fukata S, Kamada M, Inoue K, Oko K, Nakajima H, et
al: IgG4-related disease of the paratestis in a patient with Wells
syndrome: A case report. Diagn Pathol. 9:2252014. View Article : Google Scholar : PubMed/NCBI
|
10
|
Yamamoto H, Yamaguchi H, Aishima S, Oda Y,
Kohashi K, Oshiro Y and Tsuneyoshi M: Inflammatory myofibroblastic
tumor versus IgG4-related sclerosing disease and inflammatory
pseudotumor: A comparative clinicopathologic study. Am J Surg
Pathol. 33:1330–1340. 2009. View Article : Google Scholar : PubMed/NCBI
|
11
|
Zen Y, Kitagawa S, Minato H, Kurumaya H,
Katayanagi K, Masuda S, Niwa H, Fujimura M and Nakanuma Y:
IgG4-positive plasma cells in inflammatory pseudotumor (plasma cell
granuloma) of the lung. Hum Pathol. 36:710–717. 2005. View Article : Google Scholar : PubMed/NCBI
|
12
|
Bhagat P, Bal A, Das A, Singh N and Singh
H: Pulmonary inflammatory myofibroblastic tumor and IgG4-related
inflammatory pseudotumor: A diagnostic dilemma. Virchows Arch.
463:743–747. 2013. View Article : Google Scholar : PubMed/NCBI
|
13
|
Makhlouf HR and Sobin LH: Inflammatory
myofibroblastic tumors (inflammatory pseudotumors) of the
gastrointestinal tract: How closely are they related to
inflammatory fibroid polyps? Hum Pathol. 33:307–315. 2002.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Dishop MK, Warner BW, Dehner LP, Kriss VM,
Greenwood MF, Geil JD and Moscow JA: Successful treatment of
inflammatory myofibroblastic tumor with malignant transformation by
surgical resection and chemotherapy. J Pediatr Hematol Oncol.
25:153–158. 2003. View Article : Google Scholar : PubMed/NCBI
|
15
|
Lee MH, Lee HB, Lee YC, Rhee YK, Lee EJ,
Chung MJ, Jin GY, Kweon EY and Park SJ: Bilateral multiple
inflammatory myofibroblastic tumors of the lung successfully
treated with corticosteroids. Lung. 189:433–435. 2011. View Article : Google Scholar : PubMed/NCBI
|
16
|
Diop B, Konate I, Ka S, Sall I, Fall D,
Dieng M and Wone Y: Mesenteric myofibroblastic tumor: NSAID therapy
after incomplete resection. J Visc Surg. 148:e311–e314. 2011.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Schaeffer CJ, Minai OA, Sharma N, Kanne JP
and Mohammed TL: Inflammatory myofibroblastic tumor of the lung:
Recurrence after steroid treatment. J Thorac Imaging. 23:191–193.
2008. View Article : Google Scholar : PubMed/NCBI
|
18
|
He CY, Dong GH and Liu HG: Recurrent
laryngeal inflammatory myofibroblastic tumor with positive
anaplastic lymphoma kinase mimicking recurrent respiratory
papillomatosis: A case report. World J Surg Oncol. 12:542014.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Satomi T, Watanabe M, Matsubayashi J,
Nagao T and Chiba H: A successfully treated inflammatory
myofibroblastic tumor of the mandible with long-term follow-up and
review of the literature. Med Mol Morphol. 43:185–191. 2010.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Lovly CM, Gupta A, Lipson D, Otto G,
Brennan T, Chung CT, Borinstein SC, Ross JS, Stephens PJ, Miller
VA, et al: Inflammatory myofibroblastic tumors harbor multiple
potentially actionable kinase fusions. Cancer Discov. 4:889–895.
2014. View Article : Google Scholar : PubMed/NCBI
|
21
|
Jacob SV, Reith JD, Kojima AY, Williams
WD, Liu C and Duckworth Vila L: An unusual case of systemic
inflammatory myofibroblastic tumor with successful treatment with
ALK-Inhibitor. Case Rep Pathol. 2014:4703402014.PubMed/NCBI
|
22
|
Tothova Z and Wagner AJ: Anaplastic
lymphoma kinase-directed therapy in inflammatory myofibroblastic
tumors. Curr Opin Oncol. 24:409–413. 2012. View Article : Google Scholar : PubMed/NCBI
|
23
|
Qiu JF, Shi YJ, Fang L, Wang HF and Zhang
MC: High fever as an initial symptom of primary gastric
inflammatory myofibroblastic tumor in an adult woman. Int J Clin
Exp Med. 7:1468–1473. 2014.PubMed/NCBI
|
24
|
Zhou R, Xiang J, Chen Z, Li Z and Hong J:
Fever of unknown origin as a presentation of colonic inflammatory
myofibroblastic tumor in a 36-year-old female: A case report. Oncol
Lett. 7:1566–1568. 2014.PubMed/NCBI
|
25
|
Kuppe C, Westphal S, Bücher E, Moeller MJ,
Heintz B, Schneider ME and Floege J: Macrophage activation syndrome
in a patient with pulmonary inflammatory myofibroblastic tumour.
Allergy Asthma Clin Immunol. 8:62012. View Article : Google Scholar : PubMed/NCBI
|
26
|
Chavez C and Hoffman MA: Complete
remission of ALK-negative plasma cell granuloma (inflammatory
myofibroblastic tumor) of the lung induced by celecoxib: A case
report and review of the literature. Oncol Lett. 5:1672–1676.
2013.PubMed/NCBI
|
27
|
Tamaoki J, Kadota J and Takizawa H:
Clinical implications of the immunomodulatory effects of
macrolides. Am J Med. 117(Suppl 9A): 5S–11S. 2004.PubMed/NCBI
|
28
|
Siddiqui J: Immunomodulatory effects of
macrolides: Implications for practicing clinicians. Am J Med.
117(Suppl 9A): 26S–29S. 2004.PubMed/NCBI
|
29
|
Giamarellos-Bourboulis EJ: Macrolides
beyond the conventional antimicrobials: A class of potent
immunomodulators. Int J Antimicrob Agents. 31:12–20. 2008.
View Article : Google Scholar : PubMed/NCBI
|
30
|
Zarogoulidis P, Papanas N, Kioumis I,
Chatzaki E, Maltezos E and Zarogoulidis K: Macrolides: From in
vitro anti-inflammatory and immunomodulatory properties to
clinical practice in respiratory diseases. Eur J Clin Pharmacol.
68:479–503. 2012. View Article : Google Scholar : PubMed/NCBI
|
31
|
Marjanović N, Bosnar M, Michielin F, Willé
DR, Anić-Milić T, Culić O, Popović-Grle S, Bogdan M, Parnham MJ and
Haber Eraković V: Macrolide antibiotics broadly and distinctively
inhibit cytokine and chemokine production by COPD sputum cells
in vitro. Pharmacol Res. 63:389–397. 2011. View Article : Google Scholar : PubMed/NCBI
|
32
|
Thanou-Stavraki A, Aberle T, Aksentijevich
I, Bane BL and Harley JB: Clarithromycin in adult-onset still's
disease: A potentially useful therapeutic. J Clin Rheumatol.
17:373–376. 2011. View Article : Google Scholar : PubMed/NCBI
|
33
|
Urasaki Y, Nori M, Iwata S, Sasaki T,
Hosono O, Kawasaki H, Tanaka H, Dang NH, Ikeda E and Morimoto C:
Roxithromycin specifically inhibits development of collagen induced
arthritis and production of proinflammatory cytokines by human T
cells and macrophages. J Rheumatol. 32:1765–1774. 2005.PubMed/NCBI
|
34
|
Gui GP, Thomas PR, Tizard ML, Lake J,
Sanderson JD and Hermon-Taylor J: Two-year-outcomes analysis of
Crohn's disease treated with rifabutin and macrolide antibiotics. J
Antimicrob Chemother. 39:393–400. 1997. View Article : Google Scholar : PubMed/NCBI
|